Atlas Logo
A Real-world Registry Study of Multidisciplinary Collaborative Diagnosis and Treatment Model for Cardioembolic Stroke
BACK
Sample details

The aim of this study was to establish a multidisciplinary assisted diagnosis and treatment model for patients at high risk of cardioembolic stroke, manage and collect the diagnosis, treatment and prognosis data of patients. Around 1,200 patients at high-risk of cardioembolic stroke were enrolled into the study from September 2022 to September 2023 from the Second Affiliated Hospital of Nanchang University and sub-centers of hospitals at all levels in Jiangxi Province, China.

Study design
Registry, Cohort - clinical

Number of participants at first data collection

~1,200 (participants)

Age at first data collection

Varied (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
No

Sample features

Patients and clinical populations
Dataset details

Country

China

Year of first data collection

2022

Primary Institutions

Second Affiliated Hospital of Nanchang University (南昌大学第二附属医院, SAHNU)

Links

clinicaltrials.gov/show/NCT05498909

app.trialscreen.org/trials/cardioembolic-stroke-real-world-registry-multidisciplinary-collaborative-study-nct05498909

Profile paper DOI
Not available

Funders

No funding information available

Ongoing?
Yes

Data types collected

dataLinkage
Quantitative data collection
  • Secondary data
Qualitative data collection
  • None
Neuroimaging data collection
  • None
Linked or secondary data
  • Healthcare data
  • Mortality data
Features

Engagement

  • None
  • Keywords

    Cardiovascular health and disease
    Interventions
    Morbidity and mortality
    Patient data
    Stroke
    Treatment experiences and outcomes
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2024 Louise Arseneault

    Platform by Delosis